Interventional Cardiology News and Research

RSS
Catheter-based aortic valve replacement can help a broad range of heart patients, study shows

Catheter-based aortic valve replacement can help a broad range of heart patients, study shows

Study finds no difference in physician-patient gender concordance

Study finds no difference in physician-patient gender concordance

Randomized clinical trials compare effects of coronary revascularization versus medical therapy alone

Randomized clinical trials compare effects of coronary revascularization versus medical therapy alone

Novel technology can be effective non-surgical treatment option for congenital heart disease patients

Novel technology can be effective non-surgical treatment option for congenital heart disease patients

Analysis reveals benefits of using longer covered stent in patients with rare congenital heart disease

Analysis reveals benefits of using longer covered stent in patients with rare congenital heart disease

Abbott’s new imaging platform powered by Ultreon 1.0 Software launches in Europe

Abbott’s new imaging platform powered by Ultreon 1.0 Software launches in Europe

Study reports 70% decline in heart attack patients who sought care during the pandemic

Study reports 70% decline in heart attack patients who sought care during the pandemic

New device minimizes hemostasis time for patients receiving cardiac catherization

New device minimizes hemostasis time for patients receiving cardiac catherization

SCAI releases expert consensus statement on best practices in cardiac catheterization lab

SCAI releases expert consensus statement on best practices in cardiac catheterization lab

Non-traditional risk factors impact African American patients with coronary artery disease

Non-traditional risk factors impact African American patients with coronary artery disease

Abbott’s XIENCE™ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients

Abbott’s XIENCE™ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients

Vaccination of health care workers resulted in notable reduction of COVID-19 cases

Vaccination of health care workers resulted in notable reduction of COVID-19 cases

New examination method identifies high-risk plaques likely to cause adverse cardiac events

New examination method identifies high-risk plaques likely to cause adverse cardiac events

Stents or bypass surgery can improve outcomes in patients with stable ischemic heart disease

Stents or bypass surgery can improve outcomes in patients with stable ischemic heart disease

New method of guidance for heart bypass surgery to be tested on patients for the first time

New method of guidance for heart bypass surgery to be tested on patients for the first time

Serious health inequities exist for racial and ethnic minorities with heart problems

Serious health inequities exist for racial and ethnic minorities with heart problems

TCT 2020 Shark Tank Innovation Competition won by OnSight Medical

TCT 2020 Shark Tank Innovation Competition won by OnSight Medical

MITHRAS trial investigates superiority of TMVR-induced iASD over medical therapy

MITHRAS trial investigates superiority of TMVR-induced iASD over medical therapy

REFLECT II clinical trial evaluates safety and efficacy of cerebral embolic deflection filter

REFLECT II clinical trial evaluates safety and efficacy of cerebral embolic deflection filter

New self-expanding bioprosthetic valve used in TAVR fails to demonstrate non-inferiority

New self-expanding bioprosthetic valve used in TAVR fails to demonstrate non-inferiority

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.